EZH2 is downstream of the pRB-E2F pathway, essential for proliferation and amplified in cancer.

The hallmarks of cancer

Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219 · see citing works

Tissue microarrays for high-throughput molecular profiling of tumor specimens

Kononen, J., Bubendorf, L., Kallionimeni, A., Barlund, M. T., Schraml, P., Leighton, S. B., Torhorst, J. K. H., Mihatsch, M. J., Sauter, G., & Kallionimeni, O.-P. (1998) · Nature Medicine · doi:10.1038/nm0798-844 · Cited by 4,101 · see citing works

Role of Histone H3 Lysine 27 Methylation in Polycomb-Group Silencing

Cao, R., Wang, L., Wang, H., Xia, L., Erdjument-Bromage, H., Tempst, P., Jones, R. S., & Zhang, Y. (2002) · Science · doi:10.1126/science.1076997 · Cited by 3,775 · see citing works

The polycomb group protein EZH2 is involved in progression of prostate cancer

Varambally, S., Dhanasekaran, S. M., Zhou, M., Barrette, T. R., Kumar-Sinha, C., Sanda, M. G., Ghosh, D., Pienta, K. J., Sewalt, R. G. A. B., Otte, A. P., et al. (2002) · Nature · doi:10.1038/nature01075 · Cited by 2,717 · see citing works

The regulation of E2F by pRB-family proteins.

Dyson, N. (1998) · Genes & Development · doi:10.1101/gad.12.15.2245 · Cited by 2,317 · see citing works

Histone methyltransferase activity associated with a human multiprotein complex containing the Enhancer of Zeste protein

Kuzmichev, A., Nishioka, K., Erdjument-Bromage, H., Tempst, P., & Reinberg, D. (2002) · Genes & Development · doi:10.1101/gad.1035902 · Cited by 1,596 · see citing works

The oncogene and Polycomb-group gene bmi-1 regulates cell proliferation and senescence through the ink4a locus

Jacobs, J. J. L., Kieboom, K., Marino, S., DePinho, R. A., & van Lohuizen, M. (1999) · Nature · doi:10.1038/16476 · Cited by 1,580 · see citing works

Histone Methyltransferase Activity of a Drosophila Polycomb Group Repressor Complex

Müller, J., Hart, C. M., Francis, N. J., Vargas, M. L., Sengupta, A. K., Wild, B., Miller, E., O’Connor, M. B., Kingston, R. E., & Simon, J. A. (2002) · Cell · doi:10.1016/s0092-8674(02)00976-5 · Cited by 1,553 · see citing works

Drosophila Enhancer of Zeste/ESC Complexes Have a Histone H3 Methyltransferase Activity that Marks Chromosomal Polycomb Sites

Czermin, B., Melfi, R., McCabe, D., Seitz, V., Imhof, A., & Pirrotta, V. (2002) · Cell · doi:10.1016/s0092-8674(02)00975-3 · Cited by 1,536 · see citing works

Microarray analysis reveals a major direct role of DNA copy number alteration in the transcriptional program of human breast tumors

Pollack, J. R., Sørlie, T., Perou, C. M., Rees, C. A., Jeffrey, S. S., Lønning, P. E., Tibshirani, R. J., Botstein, D., Børresen‐Dale, A., & Brown, P. O. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.162471999 · Cited by 1,167 · see citing works

Sibling rivalry in the E2F family

Trimarchi, J. M., & Lees, J. A. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm714 · Cited by 1,158 · see citing works

E2F integrates cell cycle progression with DNA repair, replication, and G ₂ /M checkpoints

Ren, B., Cam, H., Takahashi, Y., Volkert, T., Terragni, J., Young, R. A., & Dynlacht, B. D. (2002) · Genes & Development · doi:10.1101/gad.949802 · Cited by 1,125 · see citing works

The Polycomb-Group GeneEzh2 Is Required for Early Mouse Development

O’Carroll, D., Erhardt, S., Pagani, M., Barton, S. C., Surani, M. A., & Jenuwein, T. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.13.4330-4336.2001 · Cited by 908 · see citing works

E2Fs regulate the expression of genes involved in differentiation, development, proliferation, and apoptosisPreprint

Müller, H., Bracken, A. P., Vernell, R., Moroni, M. C., Christians, F. C., Grassilli, E., Prosperini, E., Vigo, E., Oliner, J. D., & Helin, K. (2001) · Genes & Development · doi:10.1101/gad.864201 · Cited by 752 · see citing works

Cellular Senescence

Sherr, C. J., & DePinho, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)00046-5 · Cited by 745 · see citing works

Targeted disruption of the three Rb-related genes leads to loss of G ₁ control and immortalization

Sage, J., Mulligan, G. J., Attardi, L. D., Miller, A., Chen, S., Williams, B., Theodorou, E., & Jacks, T. (2000) · Genes & Development · doi:10.1101/gad.843200 · Cited by 582 · see citing works

Binding of c-Myc to chromatin mediates mitogen-induced acetylation of histone H4 and gene activationPreprint

Frank, S. R., Schroeder, M., Fernandez, P. C., Taubert, S., & Amati, B. B. (2001) · Genes & Development · doi:10.1101/gad.906601 · Cited by 498 · see citing works

Regulation of cell proliferation by the E2F transcription factors

Helin, K. (1998) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(98)80058-0 · Cited by 491 · see citing works

Isolating human transcription factor targets by coupling chromatin immunoprecipitation and CpG island microarray analysisPreprint

Weinmann, A. S., Yan, P. S., Oberley, M. J., Huang, T. H. ‐., & Farnham, P. (2002) · Genes & Development · doi:10.1101/gad.943102 · Cited by 443 · see citing works

The retinoblastoma gene family in differentiation and development

Lipinski, M. M., & Jacks, T. (1999) · Oncogene · doi:10.1038/sj.onc.1203244 · Cited by 404 · see citing works

Frequent fusion of the JAZF1 and JJAZ1 genes in endometrial stromal tumors

Koontz, J. I., Soreng, A. L., Nucci, M. R., Kuo, F. C., Pauwels, P., BERGHE, H. V. D., Cin, P. D., Fletcher, J. A., & Sklar, J. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.101132598 · Cited by 391 · see citing works

Use of Chromatin Immunoprecipitation To Clone Novel E2F Target Promoters

Weinmann, A. S., Bartley, S. M., Zhang, T., Zhang, M. Q., & Farnham, P. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.20.6820-6832.2001 · Cited by 384 · see citing works

The Polycomb group protein EZH2 is upregulated in proliferating, cultured human mantle cell lymphoma

Visser, H. P. J., Gunster, M. J., Kluin‐Nelemans, H. C., Manders, E. M. M., Raaphorst, F. M., Meijer, C. J. L. M., Willemze, R., & Otte, A. P. (2001) · British Journal of Haematology · doi:10.1046/j.1365-2141.2001.02641.x · Cited by 236 · see citing works

Polycomb repression: from cellular memory to cellular proliferation and cancer

Jacobs, J. J. L., & van Lohuizen, M. (2002) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(02)00052-5 · Cited by 209 · see citing works

Linking the Rb and Polycomb Pathways

Dahiya, A., Wong, S., Gonzalo, S., Gavin, M., & Dean, D. C. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00346-x · Cited by 195 · see citing works

A Screen for New Trithorax Group Genes Identified little imaginal discs, the Drosophila melanogaster Homologue of Human Retinoblastoma Binding Protein 2

Gildea, J. J., López, R., & Shearn, A. (2000) · Genetics · doi:10.1093/genetics/156.2.645 · Cited by 190 · see citing works

The Polycomb group — no longer an exclusive club?

Brock, H. W., & van Lohuizen, M. (2001) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(00)00176-3 · Cited by 149 · see citing works

Expression pattern of the Kallmann syndrome gene in the olfactory system suggests a role in neuronal targeting

Rugarli, E. I., Lutz, B., Kuratani, S., Wawersik, S., Borsani, G., Ballabio, A., & Gregor Eichele, C. (1993) · Nature Genetics · doi:10.1038/ng0593-19 · Cited by 148 · see citing works

Induction of cyclin E–cdk2 kinase activity, E2F‐dependent transcription and cell growth by Myc are genetically separable events

Beier, R., Bürgin, A., Kiermaier, A. C., Fero, M. L., Karsunky, H., Saffrich, R., Möröy, T., Ansorge, W. J., Roberts, J., & Eilers, M. (2000) · The EMBO Journal · doi:10.1093/emboj/19.21.5813 · Cited by 114 · see citing works

Requirement of Cyclin E-Cdk2 Inhibition in p16 INK4a -Mediated Growth Suppression

Jiang, H. N., Chou, H. S., & Zhu, L. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.9.5284 · Cited by 112 · see citing works

The human EZH2 gene: genomic organisation and revised mapping in 7q35 within the critical region for malignant myeloid disorders

Cardoso, C., Mignon, C., Hetet, G., Grandchamps, B., Fontés, M., & Colleaux, L. (2000) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5200439 · Cited by 110 · see citing works

E(z): a polycomb group gene or a trithorax group gene?

LaJeunesse, D., & Shearn, A. (1996) · Development · doi:10.1242/dev.122.7.2189 · Cited by 101 · see citing works

Cutting Edge: Polycomb Gene Expression Patterns Reflect Distinct B Cell Differentiation Stages in Human Germinal Centers

Raaphorst, F. M., van Kemenade, F. J., Fieret, E. J. H., Hamer, K. M., Satijn, D. P. E., Otte, A. P., & Meijer, C. J. L. M. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.1.1 · Cited by 98 · see citing works

Microarray analysis reveals a major direct role of DNA copy number alteration in the transcriptional program of human breast tumors

Botstein, D., Lonning, P. E., Tibshirani, R., et al. (2020) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/zsqc-zc97 · Cited by 94 · see citing works

Characterization of a high copy number amplification at 6q24 in pancreatic cancer identifies c-myb as a candidate oncogene.

Wallrapp, C., Müller-Pillasch, F., Solinas‐Toldo, S., Lichter, P., Friess, H., Büchler, M. W., Fink, T., Adler, G., & Gress, T. M. (1997) · PubMed · Cited by 87 · see citing works

High-Throughput Copy Number Analysis of 17q23 in 3520 Tissue Specimens by Fluorescence in Situ Hybridization to Tissue Microarrays

Andersen, C. L., Monni, O. M., Wagner, U., Kononen, J., Barlund, M. T., Bucher, C., Haas, P., Nocito, A., Bissig, H., Sauter, G., et al. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64158-2 · Cited by 73 · see citing works

p16INK4a, but not constitutively active pRb, can impose a sustained G1 arrest: molecular mechanisms and implications for oncogenesis

Lukas, J., Sørensen, C. S., Lukas, C., Santoni‐Rugiu, E., & Bártek, J. (1999) · Oncogene · doi:10.1038/sj.onc.1202777 · Cited by 73 · see citing works

Distinct BMI-1 and EZH2 Expression Patterns in Thymocytes and Mature T Cells Suggest a Role for Polycomb Genes in Human T Cell Differentiation

Raaphorst, F. M., Otte, A. P., van Kemenade, F. J., Blokzijl, T., Fieret, E. J. H., Hamer, K. M., Satijn, D. P. E., & Meijer, C. J. L. M. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.10.5925 · Cited by 69 · see citing works

Identification and characterization of a 19q12 amplicon in esophageal adenocarcinomas reveals cyclin E as the best candidate gene for this amplicon.

Lin, L., Prescott, M. S., Zhu, Z., Singh, P., Chun, S., Kuick, R. D., Hanash, S., Orringer, M. B., Glover, T. W., & Beer, D. G. (2000) · PubMed · Cited by 57 · see citing works

Xenopus Embryonic E2F Is Required for the Formation of Ventral and Posterior Cell Fates during Early Embryogenesis

Suzuki, A., & Hemmati‐Brivanlou, A. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)80418-9 · Cited by 53 · see citing works

A role for the DP subunit of the E2F transcription factor in axis determination during Drosophila oogenesis

Myster, D. L., Bonnette, P. C., & Duronio, R. J. (2000) · Development · doi:10.1242/dev.127.15.3249 · Cited by 51 · see citing works

Proliferative involvement of ENX‐1, a putative human Polycomb group gene, in haematopoietic cells

Fukuyama, T., Otsuka, T., Shigematsu, H., Uchida, N., Arima, F., Ohno, Y., Iwasaki, H., Fukuda, T., & Niho, Y. (2000) · British Journal of Haematology · doi:10.1046/j.1365-2141.2000.01914.x · Cited by 30 · see citing works

Linking the Rb and Polycomb Pathways

Dahiya, A., Wong, S., Gonzalo, S., Gavin, M., & Dean, D. C. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00241-7 · Cited by 9 · see citing works

A role for the DP subunit of the E2F transcription factor in axis determination during Drosophila oogenesis

The University of North Carolina at Chapel Hill University Libraries (2021) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/37pp-ha26 · Cited by 2 · see citing works

The Epigenomics of Cancer

Jones, P. A., & Baylin, S. B. (2007) · Cell · doi:10.1016/j.cell.2007.01.029 · Cited by 4,515 · see citing works

Epigenetics in Cancer

Esteller, M. (2008) · New England Journal of Medicine · doi:10.1056/nejmra072067 · Cited by 3,681 · see citing works

The Polycomb complex PRC2 and its mark in life

Margueron, R., & Reinberg, D. (2011) · Nature · doi:10.1038/nature09784 · Cited by 3,347 · see citing works

Mechanisms of Cellular Senescence: Cell Cycle Arrest and Senescence Associated Secretory Phenotype

Kumari, R., & Jat, P. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.645593 · Cited by 1,622 · see citing works

Targeting EZH2 in cancer

Kim, K. H., & Roberts, C. W. M. (2016) · Nature Medicine · doi:10.1038/nm.4036 · Cited by 1,471 · see citing works

UTX and JMJD3 are histone H3K27 demethylases involved in HOX gene regulation and development

Agger, K., Cloos, P. A., Christensen, J. F., Pasini, D., Rose, S., Rappsilber, J., Issaeva, I., Canaani, E., Salcini, A. E., & Helin, K. (2007) · Nature · doi:10.1038/nature06145 · Cited by 1,392 · see citing works

Histone Lysine Methylation Dynamics: Establishment, Regulation, and Biological Impact

Black, J. C., Rechem, C. V., & Whetstine, J. R. (2012) · Molecular Cell · doi:10.1016/j.molcel.2012.11.006 · Cited by 1,325 · see citing works

Mechanisms of Polycomb gene silencing: knowns and unknowns

Simon, J. A., & Kingston, R. E. (2009) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2763 · Cited by 1,320 · see citing works

Writing, erasing and reading histone lysine methylations

Hyun, K., Jeon, J., Park, K., & Kim, J. (2017) · Experimental & Molecular Medicine · doi:10.1038/emm.2017.11 · Cited by 1,250 · see citing works

Polycomb silencers control cell fate, development and cancer

Sparmann, A., & van Lohuizen, M. (2006) · Nature reviews. Cancer · doi:10.1038/nrc1991 · Cited by 1,294 · see citing works

Genome-wide mapping of Polycomb target genes unravels their roles in cell fate transitionsPreprint

Bracken, A. P., Dietrich, N., Pasini, D., Hansen, K. H., & Helin, K. (2006) · Genes & Development · doi:10.1101/gad.381706 · Cited by 1,258 · see citing works

Mechanisms and functions of cellular senescence

Herranz, N., & Gil, J. (2018) · Journal of Clinical Investigation · doi:10.1172/jci95148 · Cited by 1,232 · see citing works

Polycomb-mediated methylation on Lys27 of histone H3 pre-marks genes for de novo methylation in cancer

Schlesinger, Y., Straussman, R., Keshet, I., Farkash, S., Hecht, M., Zimmerman, J., Eden, E., Yakhini, Z., Ben-Shushan, E., Reubinoff, B. E., et al. (2007) · Nature Genetics · doi:10.1038/ng1950 · Cited by 1,226 · see citing works

Rb1 and Trp53 cooperate to suppress prostate cancer lineage plasticity, metastasis, and antiandrogen resistance

Ku, S., Rosario, S. R., Wang, Y., Mu, P., Seshadri, M., Goodrich, Z., Goodrich, M. M., Labbé, D. P., Gomez, E. C., Wang, J., et al. (2017) · Science · doi:10.1126/science.aah4199 · Cited by 1,093 · see citing works

Genomic Loss of microRNA-101 Leads to Overexpression of Histone Methyltransferase EZH2 in Cancer

Varambally, S., Cao, Q., Mani, R. S., Shankar, S., Wang, X., Ateeq, B., Laxman, B., Cao, X., Jing, X., Ramnarayanan, K., et al. (2008) · Science · doi:10.1126/science.1165395 · Cited by 1,048 · see citing works

Histone Modifications and CancerPreprint

Audia, J. E., & Campbell, R. M. (2016) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a019521 · Cited by 1,024 · see citing works

Large-scale meta-analysis of cancer microarray data identifies common transcriptional profiles of neoplastic transformation and progression

Rhodes, D. R., Yu, J., Sundaram, S. K., Deshpande, N., Varambally, R., Ghosh, D., Barrette, T. R., Pandey, A., & Chinnaiyan, A. M. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0401994101 · Cited by 1,010 · see citing works

Nuclear lamins: major factors in the structural organization and function of the nucleus and chromatinPreprint

Dechat, T., Pfleghaar, K., Sengupta, K., Shimi, T., Shumaker, D. K., Solimando, L., & Goldman, R. D. (2008) · Genes & Development · doi:10.1101/gad.1652708 · Cited by 1,001 · see citing works

Suz12 is essential for mouse development and for EZH2 histone methyltransferase activity

Pasini, D., Bracken, A. P., Jensen, M. R., Denchi, E. L., & Helin, K. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600402 · Cited by 910 · see citing works

The functions of E(Z)/EZH2-mediated methylation of lysine 27 in histone H3

Cao, R., & Zhang, Y. (2004) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2004.02.001 · Cited by 907 · see citing works

Interplay between the Cancer Genome and Epigenome

Shen, H., & Laird, P. W. (2013) · Cell · doi:10.1016/j.cell.2013.03.008 · Cited by 912 · see citing works

Pharmacologic disruption of Polycomb-repressive complex 2-mediated gene repression selectively induces apoptosis in cancer cells

Tan, J., Yang, X., Zhuang, L., Jiang, X., Chen, W., Lee, P. L., Karuturi, R. K. M., Tan, P. B. O., Liu, E. T., & Yu, Q. (2007) · Genes & Development · doi:10.1101/gad.1524107 · Cited by 895 · see citing works

Ezh1 and Ezh2 Maintain Repressive Chromatin through Different Mechanisms

Margueron, R., Li, G., Sarma, K., Blais, A., Zavadil, J., Woodcock, C. L. F., Dynlacht, B. D., & Reinberg, D. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.11.004 · Cited by 889 · see citing works

Histones: annotating chromatin

Campos, E. I., & Reinberg, D. (2009) · Annual Review of Genetics · doi:10.1146/annurev.genet.032608.103928 · Cited by 852 · see citing works

Roles of the EZH2 histone methyltransferase in cancer epigenetics

Simon, J. A., & Lange, C. A. (2008) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2008.07.010 · Cited by 860 · see citing works

EZH2 Expression Is Associated With High Proliferation Rate and Aggressive Tumor Subgroups in Cutaneous Melanoma and Cancers of the Endometrium, Prostate, and Breast

Bachmann, I. M., HALVORSEN, O. J., Collett, K., Stefansson, I. M., Straume, O., Haukaas, S. A., Salvesen, H. B., Otte, A. P., & Akslen, L. A. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.01.5180 · Cited by 848 · see citing works

The Polycomb group proteins bind throughout the <i>INK4A-ARF</i> locus and are disassociated in senescent cells

Bracken, A. P., Kleine-Kohlbrecher, D., Dietrich, N., Pasini, D., Gargiulo, G., Beekman, C., Theilgaard-Mönch, K., Minucci, S., Porse, B. T., Marine, J.-C., et al. (2007) · Genes &amp; Development · doi:10.1101/gad.415507 · Cited by 850 · see citing works

SUZ12 Is Required for Both the Histone Methyltransferase Activity and the Silencing Function of the EED-EZH2 Complex

Cao, R., & Zhang, Y. (2004) · Molecular Cell · doi:10.1016/j.molcel.2004.06.020 · Cited by 809 · see citing works

hDOT1L Links Histone Methylation to Leukemogenesis

Okada, Y., Feng, Q. F., Lin, Y.-H., Jiang, Q., Li, Y., Coffield, V. M., Su, L., Xu, G., & Zhang, Y. (2005) · Cell · doi:10.1016/j.cell.2005.02.020 · Cited by 819 · see citing works

A selective inhibitor of EZH2 blocks H3K27 methylation and kills mutant lymphoma cells

Knutson, S. K., Wigle, T. J., Warholic, N. M., Sneeringer, C. J., Allain, C. J., Klaus, C. R., Sacks, J. D., Raimondi, A., Majer, C. R., Song, J., et al. (2012) · Nature Chemical Biology · doi:10.1038/nchembio.1084 · Cited by 776 · see citing works

The unfolded protein response protects human tumor cells during hypoxia through regulation of the autophagy genes MAP1LC3B and ATG5

Rouschop, K. M. A., van den Beucken, T., Dubois, L., Niessen, H., Bussink, J., Savelkouls, K., Keulers, T., Mujcic, H., Landuyt, W., Voncken, J. W., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci40027 · Cited by 829 · see citing works

Stem Cells and Cancer

Valk-Lingbeek, M. E., Bruggeman, S. W. M., & van Lohuizen, M. (2004) · Cell · doi:10.1016/j.cell.2004.08.005 · Cited by 743 · see citing works

SMYD3 encodes a histone methyltransferase involved in the proliferation of cancer cells

Hamamoto, R., Furukawa, Y., Morita, M., Iimura, Y., Pittella-Silva, F., Li, M., Yagyu, R., & Nakamura, Y. (2004) · Nature Cell Biology · doi:10.1038/ncb1151 · Cited by 738 · see citing works

Histone Methylation by PRC2 Is Inhibited by Active Chromatin Marks

Schmitges, F. W., Prusty, A. B., Faty, M., Stützer, A., Lingaraju, G. M., Aiwazian, J., Sack, R., Heß, D., Li, L., Zhou, S., et al. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.03.025 · Cited by 725 · see citing works

A model for transmission of the H3K27me3 epigenetic mark

Hansen, K. H., Bracken, A. P., Pasini, D., Dietrich, N., Gehani, S. S., Monrad, A., Rappsilber, J., Lerdrup, M., & Helin, K. (2008) · Nature Cell Biology · doi:10.1038/ncb1787 · Cited by 720 · see citing works

The Polycomb Group Protein Suz12 Is Required for Embryonic Stem Cell Differentiation

Pasini, D., Bracken, A. P., Hansen, J. B., Capillo, M., & Helin, K. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.01432-06 · Cited by 696 · see citing works

Coordinated activities of wild-type plus mutant EZH2 drive tumor-associated hypertrimethylation of lysine 27 on histone H3 (H3K27) in human B-cell lymphomas

Sneeringer, C. J., Scott, M. P., Kuntz, K. W., Knutson, S. K., Pollock, R. M., Richon, V. M., & Copeland, R. A. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1012525107 · Cited by 691 · see citing works

Polycomb Group Proteins: Multi-Faceted Regulators of Somatic Stem Cells and Cancer

Sauvageau, M., & Sauvageau, G. (2010) · Cell stem cell · doi:10.1016/j.stem.2010.08.002 · Cited by 676 · see citing works

The role of mutations in epigenetic regulators in myeloid malignancies

Shih, A. H., Abdel-Wahab, O. I., Patel, J. P., & Levine, R. L. (2012) · Nature reviews. Cancer · doi:10.1038/nrc3343 · Cited by 671 · see citing works

An Evolutionarily Conserved Function of Polycomb Silences the MHC Class I Antigen Presentation Pathway and Enables Immune Evasion in Cancer

Burr, M. L., Sparbier, C. E., Chan, K. L., Chan, Y.-C., Kersbergen, A. J., Lam, E. Y. N., Azidis-Yates, E., Vassiliadis, D., Bell, C. C., Gilan, O., et al. (2019) · Cancer Cell · doi:10.1016/j.ccell.2019.08.008 · Cited by 656 · see citing works

Epigenetic Antagonism between Polycomb and SWI/SNF Complexes during Oncogenic Transformation

Wilson, B. G., Wang, X., Shen, X., McKenna, E. S., Lemieux, M. E., Cho, Y., Koellhoffer, E. C., Pomeroy, S. L., Orkin, S. H., & Roberts, C. W. M. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.09.006 · Cited by 649 · see citing works

Gene silencing in cancer by histone H3 lysine 27 trimethylation independent of promoter DNA methylation

Kondo, Y., Shen, L., Cheng, A. S. L., Ahmed, S., Boumber, Y., Charo, C., Yamochi, T., Urano, T., Furukawa, K., Kwabi‐Addo, B., et al. (2008) · Nature Genetics · doi:10.1038/ng.159 · Cited by 618 · see citing works

Aberrant Epigenetic Landscape in Cancer: How Cellular Identity Goes Awry

Berdasco, M., & Esteller, M. (2010) · Developmental Cell · doi:10.1016/j.devcel.2010.10.005 · Cited by 623 · see citing works

Somatic mutations at EZH2 Y641 act dominantly through a mechanism of selectively altered PRC2 catalytic activity, to increase H3K27 trimethylation

Yap, D., Chu, J., Berg, T., Schapira, M., Cheng, S., Moradian, A., Morin, R. D., Mungall, A. J. J., Meissner, B., Boyle, M., et al. (2010) · Blood · doi:10.1182/blood-2010-11-321208 · Cited by 609 · see citing works

The Polycomb Ezh2 methyltransferase regulates muscle gene expression and skeletal muscle differentiationPreprint

G, C., Padova, M. D., GE, L., Lyons, G. E., & Sartorelli, V. (2004) · Genes & Development · doi:10.1101/gad.1241904 · Cited by 595 · see citing works

DZNep is a global histone methylation inhibitor that reactivates developmental genes not silenced by DNA methylation

Miranda, T. B., Cortez, C. C., Yoo, C. B., Liang, G., Abe, M., Kelly, T. K., Márquez, V. E., & Jones, P. A. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0013 · Cited by 588 · see citing works

E2F target genes: unraveling the biology

Bracken, A. P., Cirò, M., Cocito, A., & Helin, K. (2004) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2004.06.006 · Cited by 583 · see citing works

Polycomb group proteins: navigators of lineage pathways led astray in cancer

Bracken, A. P., & Helin, K. (2009) · Nature reviews. Cancer · doi:10.1038/nrc2736 · Cited by 562 · see citing works

Proteomic Profiling Identifies Dysregulated Pathways in Small Cell Lung Cancer and Novel Therapeutic Targets Including PARP1

Byers, L. A., Wang, J., Nilsson, M. B., Fujimoto, J., Saintigny, P., Yordy, J. S., Giri, U. P., Peyton, M., Fan, Y. H., Diao, L., et al. (2012) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0112 · Cited by 553 · see citing works

RBP2 Belongs to a Family of Demethylases, Specific for Tri-and Dimethylated Lysine 4 on Histone 3

Christensen, J. F., Agger, K., Cloos, P. A., Pasini, D., Rose, S., Sennels, L., Rappsilber, J., Hansen, K. H., Salcini, A. E., & Helin, K. (2007) · Cell · doi:10.1016/j.cell.2007.02.003 · Cited by 554 · see citing works

Aberrations of EZH2 in Cancer

Chase, A., & Cross, N. C. P. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2156 · Cited by 548 · see citing works

Epigenetic balance of gene expression by Polycomb and COMPASS families

Piunti, A., & Shilatifard, A. (2016) · Science · doi:10.1126/science.aad9780 · Cited by 524 · see citing works

Selective Inhibition of EZH2 by EPZ-6438 Leads to Potent Antitumor Activity in EZH2 -Mutant Non-Hodgkin Lymphoma

Knutson, S. K., Kawano, S., Minoshima, Y., Warholic, N. M., Huang, K., Xiao, Y., Kadowaki, T., Uesugi, M., Kuznetsov, G., Kumar, N., et al. (2014) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-13-0773 · Cited by 529 · see citing works

Silencing of human polycomb target genes is associated with methylation of histone H3 Lys 27Preprint

Kirmizis, A., Reinberg, D., Farnham, P., Margueron, R., Reinberg, D., Green, R., & Farnham, P. J. (2004) · Genes & Development · doi:10.1101/gad.1200204 · Cited by 493 · see citing works

Unravelling the biology of SCLC: implications for therapy

Sabari, J. K., Lok, B. H., Laird, J. H., Poirier, J. T., & Rudin, C. M. (2017) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2017.71 · Cited by 495 · see citing works

Mutation of A677 in histone methyltransferase EZH2 in human B-cell lymphoma promotes hypertrimethylation of histone H3 on lysine 27 (H3K27)

McCabe, M. T., Graves, A. P., Ganji, G., Diaz, E., Halsey, W. S., Jiang, Y., Smitheman, K. N., Ott, H. M., Pappalardi, M. B., Allen, K. E., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1116418109 · Cited by 493 · see citing works

Epigenetics and cancer

Lund, A. H., & van Lohuizen, M. (2004) · Genes &amp; Development · doi:10.1101/gad.1232504 · Cited by 489 · see citing works

Protein methyltransferases as a target class for drug discovery

Copeland, R. A., Solomon, M. E., & Richon, V. M. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2974 · Cited by 467 · see citing works

EZH2 Is Essential for Glioblastoma Cancer Stem Cell Maintenance

Suvà, M.-L., Riggi, N., Janiszewska, M., Radovanovic, I., Provero, P., Stehle, J., Baumer, K., Bitoux, M. L., Marino, D., Cironi, L., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-1622 · Cited by 466 · see citing works

Histone lysine demethylases as targets for anticancer therapy

Højfeldt, J. W., Agger, K., & Helin, K. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd4154 · Cited by 461 · see citing works

INK4a/ARF: A multifunctional tumor suppressor locus

Sharpless, N. E. (2005) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/j.mrfmmm.2004.08.021 · Cited by 442 · see citing works

Polycomb Complex 2 Is Required for E-cadherin Repression by the Snail1 Transcription Factor

Herranz, N., Pasini, D., Diaz, V. M., Francı́, C., Gutiérrez, A., Dave, N., Escrivà, M., Hernández‐Muñoz, I., Croce, L. D., Helin, K., et al. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.00323-08 · Cited by 437 · see citing works

Regulation of Stem Cell Pluripotency and Differentiation Involves a Mutual Regulatory Circuit of the Nanog, OCT4, and SOX2 Pluripotency Transcription Factors With Polycomb Repressive Complexes and Stem Cell microRNAs

Kashyap, V., Rezende, N. C., Scotland, K. B., Shaffer, S., Persson, J. L., Gudas, L. J., & Mongan, N. P. (2009) · Stem Cells and Development · doi:10.1089/scd.2009.0113 · Cited by 434 · see citing works

Chromatin proteins and modifications as drug targets

Helin, K., & Dhanak, D. (2013) · Nature · doi:10.1038/nature12751 · Cited by 435 · see citing works

Maintaining cell identity: PRC2-mediated regulation of transcription and cancer

Comet, I. V., Riising, E. M., Leblanc, B., & Helin, K. (2016) · Nature reviews. Cancer · doi:10.1038/nrc.2016.83 · Cited by 428 · see citing works

Epigenetic regulation of cancer progression by EZH2: from biological insights to therapeutic potential

Gan, L., Yang, Y., Li, Q., Feng, Y., Liu, T., & Guo, W.-J. (2018) · Biomarker Research · doi:10.1186/s40364-018-0122-2 · Cited by 428 · see citing works

The cancer epigenome—components and functional correlatesPreprint

Ting, A. H., McGarvey, K. M., & Baylin, S. B. (2006) · Genes & Development · doi:10.1101/gad.1464906 · Cited by 416 · see citing works

Composition and histone substrates of polycomb repressive group complexes change during cellular differentiation

Kuzmichev, A., Margueron, R., Vaquero, A., Preissner, T. S., Scher, M. B., Kirmizis, A., Ouyang, X., Brockdorff, N., Abate-Shen, C. T., Farnham, P., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409875102 · Cited by 406 · see citing works

Characterization of an antagonistic switch between histone H3 lysine 27 methylation and acetylation in the transcriptional regulation of Polycomb group target genes

Pasini, D., Malatesta, M., Jung, H. R., Walfridsson, J., Willer, A., Olsson, L., Skotte, J., Wutz, A., Porse, B. T., Jensen, O. N., et al. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq244 · Cited by 399 · see citing works

Targeting histone methyltransferases and demethylases in clinical trials for cancer therapy

Morera, L., Lübbert, M., & Jung, M. (2016) · Clinical Epigenetics · doi:10.1186/s13148-016-0223-4 · Cited by 396 · see citing works

MYC stimulates EZH2 expression by repression of its negative regulator miR-26a

Sander, S., Bullinger, L., Klapproth, K., Fiedler, K., Kestler, H. A., Barth, T. F. E., Möller, P., Stilgenbauer, S., Pollack, J. R., & Wirth, T. (2008) · Blood · doi:10.1182/blood-2008-03-147645 · Cited by 394 · see citing works

CDK1-dependent phosphorylation of EZH2 suppresses methylation of H3K27 and promotes osteogenic differentiation of human mesenchymal stem cells

Wei, Y., Chen, Y.-H., Li, L., Lang, J., Yeh, S., Shi, B., Yang, C., Yang, J.-Y., Lin, C.-Y., Lai, C., et al. (2010) · Nature Cell Biology · doi:10.1038/ncb2139 · Cited by 380 · see citing works

The roles of Polycomb repressive complexes in mammalian development and cancer

Piunti, A., & Shilatifard, A. (2021) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-021-00341-1 · Cited by 382 · see citing works

The Putative Tumor Suppressor microRNA-101 Modulates the Cancer Epigenome by Repressing the Polycomb Group Protein EZH2

Friedman, J. M., Liang, G., Liu, C.-C., Wolff, E. M., Tsai, Y., Ye, W., Zhou, X. J., & Jones, P. A. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3114 · Cited by 381 · see citing works

Polycomb protein Ezh2 regulates pancreatic β-cell <i>Ink4a/Arf</i> expression and regeneration in diabetes mellitus

Chen, H., Gu, X., Su, I.-H., Bottino, R., Contreras, J. L., Tarakhovsky, A., & Kim, S. K. (2009) · Genes &amp; Development · doi:10.1101/gad.1742509 · Cited by 366 · see citing works

Patient derived organoids to model rare prostate cancer phenotypes

Puca, L., Bareja, R., Prandi, D., Shaw, R. C., Benelli, M., Karthaus, W. R., Hess, J., Sigouros, M., Donoghue, A., Kossaï, M., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-04495-z · Cited by 366 · see citing works

Histone demethylase JMJD3 contributes to epigenetic control of <i>INK4a/ARF</i> by oncogenic RAS

Barradas, M., Anderton, E., Acosta, J. C., Li, S., Banito, A., Rodriguez-Niedenführ, M., Maertens, G., Banck, M., Zhou, M.-M., Walsh, M. J., et al. (2009) · Genes &amp; Development · doi:10.1101/gad.511109 · Cited by 352 · see citing works

miR-205 Exerts Tumor-Suppressive Functions in Human Prostate through Down-regulation of Protein Kinase Cε

Gandellini, P., Folini, M., Longoni, N., Pennati, M., Binda, M., Colecchia, M., Salvioni, R., Supino, R., Moretti, R. M., Limonta, P., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2894 · Cited by 358 · see citing works

Combined epigenetic therapy with the histone methyltransferase EZH2 inhibitor 3-deazaneplanocin A and the histone deacetylase inhibitor panobinostat against human AML cells

Fiskus, W. C., Wang, Y., Sreekumar, A., Buckley, K. M., Shi, H., Jillella, A., Üstün, C., Rao, R., Fernandez, P., Chen, J., et al. (2009) · Blood · doi:10.1182/blood-2009-03-213496 · Cited by 357 · see citing works

Chromatin repressive complexes in stem cells, development, and cancer

Laugesen, A., & Helin, K. (2014) · Cell stem cell · doi:10.1016/j.stem.2014.05.006 · Cited by 352 · see citing works

Histone H2AK119 Mono-Ubiquitination Is Essential for Polycomb-Mediated Transcriptional Repression

Tamburri, S., Lavarone, E., Fernández-Pérez, D., Conway, E., Zanotti, M., Manganaro, D., & Pasini, D. (2019) · Molecular Cell · doi:10.1016/j.molcel.2019.11.021 · Cited by 347 · see citing works

Integration of Estrogen and Wnt Signaling Circuits by the Polycomb Group Protein EZH2 in Breast Cancer Cells

Shi, B., Liang, J., Yang, X., Wang, Y., Zhao, Y., Wu, H., Sun, L., Zhang, Y., Chen, Y., Li, R., et al. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.00162-07 · Cited by 341 · see citing works

Polycomb Repressive Complex 2 Is Dispensable for Maintenance of Embryonic Stem Cell Pluripotency

Chamberlain, S. J., Yee, D., & Magnuson, T. (2008) · Stem Cells · doi:10.1634/stemcells.2008-0102 · Cited by 338 · see citing works

The Histone Demethylases JMJD1A and JMJD2B Are Transcriptional Targets of Hypoxia-inducible Factor HIF

Beyer, S., Kristensen, M. M., Jensen, K. S., Johansen, J. V., & Staller, P. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m804578200 · Cited by 341 · see citing works

The degradation of EZH2 mediated by lncRNA ANCR attenuated the invasion and metastasis of breast cancer

Li, Z., Hou, P., Fan, D., Dong, M., Ma, M., Li, H., Yao, R., Li, Y., Wang, G., Geng, P., et al. (2016) · Cell Death and Differentiation · doi:10.1038/cdd.2016.95 · Cited by 337 · see citing works

Regulation of gene transcription by Polycomb proteins

Aranda, S., Martín, G. M., & Croce, L. D. (2015) · Science Advances · doi:10.1126/sciadv.1500737 · Cited by 332 · see citing works

Chromatin modifier enzymes, the histone code and cancer

Santos-Rosa, H., & Caldas, C. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2005.08.010 · Cited by 336 · see citing works

EZH2 promotes degradation of stalled replication forks by recruiting MUS81 through histone H3 trimethylation

Rondinelli, B., Gogola, E., Yücel, H., Duarte, A. A., van de Ven, M., van der Sluijs, R., Konstantinopoulos, P. A., Jonkers, J., Ceccaldi, R., Rottenberg, S., et al. (2017) · Nature Cell Biology · doi:10.1038/ncb3626 · Cited by 334 · see citing works

The role of EZH2 in tumour progression

Chang, C.-J., & Hung, M. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.551 · Cited by 332 · see citing works

EWS-FLI-1 Expression Triggers a Ewing's Sarcoma Initiation Program in Primary Human Mesenchymal Stem Cells

Riggi, N., Suvà, M.-L., Suvà, D., Cironi, L., Provero, P., Tercier, S., Joseph, J., Stehle, J., Baumer, K., Kindler, V., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-1761 · Cited by 330 · see citing works

MicroRNA-26a Targets the Histone Methyltransferase Enhancer of Zeste homolog 2 during Myogenesis

Wong, C. F., & Tellam, R. L. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m709614200 · Cited by 316 · see citing works

Expression Profiling of Serous Low Malignant Potential, Low-Grade, and High-Grade Tumors of the Ovary

Bonome, T., Lee, J.-Y., Park, D.-C., Radonovich, M., Pise-Masison, C. A., Brady, J. N., Gardner, G. J., Hao, K., Wong, W. H., Barrett, J. C., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-2240 · Cited by 315 · see citing works

Inhibitors of Protein Methyltransferases and Demethylases

Kanıskan, H. Ü., Martini, M. L., & Jin, J. J. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.6b00801 · Cited by 320 · see citing works

An allosteric PRC2 inhibitor targeting the H3K27me3 binding pocket of EED

Qi, W., Zhao, K., Gu, J., Huang, Y., Wang, Y., Zhang, H., Zhang, M., Zhang, J., Yu, Z., Li, L., et al. (2017) · Nature Chemical Biology · doi:10.1038/nchembio.2304 · Cited by 316 · see citing works

Suz12 binds to silenced regions of the genome in a cell-type-specific mannerPreprint

Squazzo, S. L., O’Geen, H., Komashko, V., Krig, S. R., Jin, V. X., Jang, S.-W., Margueron, R., Reinberg, D., Green, R., & Farnham, P. (2006) · Genome Research · doi:10.1101/gr.5306606 · Cited by 310 · see citing works

Coordinated regulation of transcriptional repression by the RBP2 H3K4 demethylase and Polycomb-Repressive Complex 2Preprint

Pasini, D., Hansen, K. H., Christensen, J. F., Agger, K., Cloos, P. A., & Helin, K. (2008) · Genes & Development · doi:10.1101/gad.470008 · Cited by 315 · see citing works

Epigenetic and Chromatin Modifiers As Targeted Therapy of Hematologic Malignancies

Bhalla, K. N. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.16.600 · Cited by 308 · see citing works

Histone methyltransferases in cancer

Albert, M., & Helin, K. (2009) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2009.10.007 · Cited by 312 · see citing works

Loss of trimethylation at lysine 27 of histone H3 is a predictor of poor outcome in breast, ovarian, and pancreatic cancers

Wei, Y., Xia, W., Zhang, Z., Liu, J., Wang, H., Adsay, V. N., Albarracin, C. T., Yu, D., Abbruzzese, J. L., Mills, G. B., et al. (2008) · Molecular Carcinogenesis · doi:10.1002/mc.20413 · Cited by 303 · see citing works

EZH2 is a mediator of EWS/FLI1 driven tumor growth and metastasis blocking endothelial and neuro-ectodermal differentiation

Richter, G. H. S., Plehm, S., Fasan, A., Rössler, S., Unland, R., Bennani-Baı̈ti, I. M., Hotfilder, M., Löwel, D., von Luettichau, I., Moßbrugger, I., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0810759106 · Cited by 304 · see citing works

The Research Progress of EZH2 Genes in Tumors

Hong-me, W. (2014) · Medical Recapitulate

Importance of Ezh2 polycomb protein in tumorigenesis process interfering with the pathway of growth suppressive key elements

Tonini, T., D’Andrilli, G., Fucito, A., Gaspa, L., & Bagella, L. (2007) · Journal of Cellular Physiology · doi:10.1002/jcp.21241 · Cited by 74 · see citing works

The role of the polycomb group protein EZH2 in the molecular pathogenesis of prostate cancer

Bryant, R. J. (2008) · OpenGrey (Institut de l'Information Scientifique et Technique)

Roles of EZH2 Histone Methyltransferase in Tumorigenesis

We, D. (2011) · Journal of International Obstetrics and Gynecology

EZH2: Not EZHY (Easy) to Deal

Deb, G., Singh, A. K., & Gupta, S. (2014) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-13-0546 · Cited by 105 · see citing works